CMI
BSX icon

Clare Market Investments’s Boston Scientific BSX Stock Holding History

Clare Market Investments’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,050
Closed -$631K – 177
2026
Q1 		$631K Buy
+10,050
New +$804K 0.13% 99
2025
Q3 		$981K Sell
10,050
-500
-5% -$51.8K 0.2% 68
2025
Q2 		$1.13M Sell
10,550
-700
-6% -$70.8K 0.25% 58
2025
Q1 		$1.13M Buy
+11,250
New +$1.13M 0.3% 46

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Clare Market Investments's BSX Position: Q2 2026 in Review

Clare Market Investments sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 10,050 shares — an estimated $631K sold.

Clare Market Investments first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $1.13M in Q1 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Clare Market Investments reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Clare Market Investments sold 10,050 Boston Scientific shares in Q2 2026, an estimated $631K.
  • Clare Market Investments first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
  • Clare Market Investments's Boston Scientific position peaked at $1.13M in Q1 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Clare Market Investments's 13F filing for Q2 2026, filed 27 Jul 2026.